Versant Capital Management, Inc Royalty Pharma PLC Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Versant Capital Management, Inc holds 2,586 shares of RPRX stock, worth $97,078. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,586
Previous 528
389.77%
Holding current value
$97,078
Previous $19,000
378.95%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RPRX
# of Institutions
507Shares Held
308MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.75 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.37 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$864 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$821 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$652 Million0.48% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...